Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy - Wikidata - wikimedia - TriplyDB

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

http://www.wikidata.org/entity/Q33751308

about

Preventive effect of danhong huayu koufuye on diabetic retinopathy in rats.

P2860

Q42142299-AF7181E4-8112-4DC3-AE54-A64C1FA3D484

P2860

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

http://www.wikidata.org/entity/Q33751308

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@ast

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@en

type

label

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@ast

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@en

prefLabel

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@ast

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@en

P1433

Q33751308-81D0B7AA-EBFB-408A-9AC6-C0ED2D41E31E

P1476

Q33751308-6D115E20-1A8C-460D-B2E8-5DC842BC5FC8

P2093

Q33751308-CC0FDB99-78ED-4EF7-A8BF-C7C1B8806000

Q33751308-DB21F964-9C78-433B-9DE1-616860404F01

P2860

Q33751308-008FA8EA-1B9E-4B9B-842A-FA1770A9E94E

Q33751308-134ACA0A-CA11-4058-B103-B6EB37A13666

Q33751308-1A938294-46AB-4CF7-AE74-472F46790CBE

Q33751308-1CF51E04-F92D-4549-AFE8-BB04D804C2CA

Q33751308-1F3B308B-0E58-4A84-8B0A-F7F32567037A

Q33751308-20FEF46D-C947-455F-AC19-8104686C31DD

Q33751308-2E28A44D-091E-466A-B7B5-37A7583B9959

Q33751308-3B183710-7E4E-477D-8523-252C4D61712B

Q33751308-3CDA1030-4186-466A-8DDD-264A74BD21A2

Q33751308-48F0BCDD-22F3-44DF-BAD4-E70A06CB0C95

P304

Q33751308-5F95E372-4E1B-436A-8FE1-6C102C51A3AF

P31

Q33751308-250D95D4-927C-43E4-860C-96659795F5D3

P356

Q33751308-F26D4644-4137-4CFE-9D85-A72F65BD10E8

P433

Q33751308-7D4C4A8B-C75A-457B-8B29-B2641DA0C93C

P478

Q33751308-0736295A-281C-4253-85BB-429049B07097

P577

Q33751308-7A5B656B-71B1-4042-9F84-17A10114C1DF

P5875

Q33751308-CA2933EF-D2B5-444E-9A89-9CBC72BBA3E1

P698

Q33751308-9911FD6A-F75D-4E95-AE47-C57FE1EE5C46

P932

Q33751308-EE64B0BF-E6BA-4893-AB02-3AC3D586B8BB

P356

MCPHARMACOL.09.27

P1433

Molecular and cellular pharmacology

P1476

Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy

@en

P2093

Jaclyn L Kovach

http://www.w3.org/2001/XMLSchema#string

Stephen G Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Ranibizumab for neovascular age-related macular degeneration

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

The potential role of PKC beta in diabetic retinopathy and macular edema.

Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.

Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.

P304

222-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4255/MCPHARMACOL.09.27

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42639921

http://www.w3.org/2001/XMLSchema#string

P698

20352067

http://www.w3.org/2001/XMLSchema#string

P932

2844984

http://www.w3.org/2001/XMLSchema#string